Emtricitabine + tenofovir alafenamide

Papers on emtricitabine + tenofovir alafenamide

4 papers

Friday, April 3

medRxivApr 3

An FDA-Approved Tenofovir Alafenamide-Based Antiretroviral Therapy Reduces Biological Age in Healthy Adults: First Human Proof-of-Concept for Retrotransposon-Targeted Gerotherapeutics

Preprint: randomized trial in 43 peopleInterventions

Saturday, January 3

GSA 2025 AbstractJan 3

Antiretroviral Therapy Alters Skeletal Muscle DNA Methylation in HIV Mice and Promotes Cellular Senescence

Experiments in miceMuscle

Wednesday, December 31

BiochimieDec 31

The antiretroviral drug emtricitabine increases kynurenine: tryptophan ratio, aryl hydrocarbon receptor activation, and cellular senescence in female mice

Experiments in miceTryptophan–kynurenine metabolism

Wednesday, January 1

GSA 2024 AbstractJan 1

THE AHR AS A POTENTIAL MEDIATOR OF MUSCULOSKELETAL FRAILTY WITH ANTI-RETROVIRAL THERAPY

Experiments in mouse cellsInterventions